Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145

Journal of Endocrinology

Volumn 154, Issue 3, 1997, Pages 535-545

  McPherson, S J ^a   Thomas, T Z ^a   Wang, H ^a   Gurusinghe, C J ^a   Risbridger, G P ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ANDROSTANOLONE; FOLLISTATIN; MYELOPID;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

ACTIVINS; ADJUVANTS, IMMUNOLOGIC; BLOTTING, SOUTHERN; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLISTATIN; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBINS; MALE; OLIGOPEPTIDES; PEPTIDES; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030833192     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1540535     Document Type: Article

References (33)

1. Batres Y, Zhang Z & Ying S-Y 1995 Expression of activins and activin receptor messenger RNAs in LNCaP cells, a human prostatic adenocarcinoma cell line. International Journal of Oncology 6 1185-1188.
2. Chomczinsky N & Sacchi P 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
3. Darbre P, Yates J, Curtis S & King RJB 1983 Effect of estradiol on human breast cancer cells in culture. Cancer Research 43 349-354.
4. van-Dissel-Emiliani FMF, Grootenhuis AJ, de Jong FH & de Rooij DG 1989 Inhibin reduces spermatogonial numbers in testes of adult mice and Chinese hamsters. Endocrinology 125 1898-1903.
5. Feng Z-M, Madigan MB & Chen C-LC 1993 Expression of type II activin receptor genes in the male and female reproductive tissues of the rat. Endocrinology 132 2593-2601.
6. Forage RG, Brown RW, Ring JM, Stewart AG, Milborrow HM, Oliver KJ, Atrache BT, Devine PL, Hudson GC, Goss NH, Tolstoshev P, Robertson DM, Doughton B, de Kretser DM, Burger HG & Findlay JK 1987 The cloning and expression of inhibin genes: subunit use as a fecundity vaccine. In Inhibin-Non-Steroidal Regulation of Follicle Stimulating Hormone Secretion, Serono Symposia Publications, vol 42, pp 89-104. Eds HG Burger, DM de Kretser, JK Findlay & M Igarashi. New York: Raven Press.
7. Furst BA, Zhang Z & Ying S-Y 1995 Expression of activin and activin receptors in human prostatic carcinoma cell line DU145. International Journal of Oncology 7 239-243.
8. Gonzalez-Manchon C & Vale W 1989 Activin-A, inhibin and transforming growth factor-β modulate growth of two gonadal cell lines. Endocrinology 125 1666-1672.
9. Healy DL, Burger HG, Mamers P, Jobling T, Bangah M, Quinn M, Grant P, Day AJ, Rome R & Campbell JJ 1993 Elevated serum inhibin concentrations in postmenopausal women with ovarian tumours. New England Journal of Medicine 329 1539-1541.
10. 3H]thymidine incorporation by rat thymocytes and 3T3 fibroblasts in vitro. Molecular and Cellular Endocrinology 61 133-138.
11. c chain. Biochemical and Biophysical Research Communications 206 608-613.
12. Hsueh AJW, Dahl KD, Vaughan J, Tucker E, Rivier J, Bardin CW & Vale W 1987 Heterodimers and homodimers of inhibin subunits have different paracrine action in the modularion of luteinizing hormone-stimulated androgen biosynthesis. Proceedings of the National Academy of Sciences of the USA 84 5082-5086.
13. Inouye S, Guo Y, DePaolo L, Shimonaka M, Ling N & Shimasaki S 1991 Recombinant expression of human FS with 315 and 288 amino acids: chemical and biological comparison with native porcine FS. Endocrinology 129 815-822.
14. Kaipia A, Toppari J, Huhtaniemi I & Paranko J 1994 Sex difference in the action of activin-A cell proliferation of differentiating rat gonad. Endocrinology 134 2165-2170.
15. Klein R, Robertson DM, Shukovskt L, Findlay JK & de Kretser DM 1991 The radioimmunoassay of follicle-stimulating hormone (FSH)-suppressing protein (FSP): stimulation of bovine granulose cell FSP secretion by FSH. Endocrinology 128 1048-1056.
16. de Kretser DM, Foulds LM, Hancock M, McFarlane J, GOSS N & Jenkin G 1994 The isolation of activin from ovine amniotic fluid. Endocrinology 134 1231-1237.
17. McFarlane JR, Foulds LM, Pisciotta A, Robertson DM & de Kretser DM 1996 Measurement of activin in biological fluids by radioimmunoassay, utilizing dissociating agents to remove the interference of FS. European Journal of Endocrinology 134 481-489.
18. Mason AJ, Hayflick JS, Ling N, Esch F, Ueno N, Ying S-Y, Guillemin R, Niall H & Seeburg PH 1985 Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β. Nature 318 659-663.
19. Mason AJ, Sullivan J, Cahir C & Farnworth PG 1996 High molecular weight forms of inhibin and activin are biologically inactive. Proceedings of the 1Oth International Congress of Endocrinology, San Francisco, USA, vol 1, p 101. Bethesda, MD: The Endocrine Society Press (Abstract).
20. Mather JP, Attie KM, Woodruff T, Rice GC & Phillips DM 1990 Activin stimulates spermatogonial proliferation in germ-Sertoli cell co-cultures from immature rat. Endocrinology 127 3206-3254.
21. Matzuk MM, Finegold MJ, Su J-GJ, Hseuh AJW & Bradley A 1992 α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360 313-319.
22. Michel U, Albiston A & Findlay K 1990 Rat follistatin: gonadal and extra gonadal expression and evidence for alternative splicing. Biochemical and Biophysical Research Communications 173 401-407.
23. Nishihara T, Okahashi N & Ueda N 1993 Activin A induces apoptotic cell death. Biochemical and Biophysical Research Communications 197 985-991.
24. Risbridger GP, Thomas T, Gurusinghe CJ & McFarlane JR 1996 Inhibin-related proteins in rat prostate. Journal of Endocrinology 149 93-99.
25. Robertson DM, Foulds LM, Prisk M & Hedger MP 1992 Inhibin/activin β-subunit monomer: isolation and characterization. Endocrinology 130 1680-1687.
26. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA & Arnheim K 1985 Enzymatic amplification of beta-globulin genomic sequences and restriction site analysis for diagnosis of sickle cell anaemia. Science 230 1350-1354.
27. Schmitt JF, Hearn MT & Risbridger GP 1996 Expression of fibrobhst growth factor-8 in adult rat tissues and human prostate carcinoma cells. Journal of Steroid Biochemistry and Molecular Biology 57 173-178.
28. Steiner MS 1993 Role of peptide growth factors in the prostate: a review. Urology 42 99-110.
29. Sugino K, Kurosawa N, Nakamura T, Takio K, Shimasaki S, Ling N, Titani K & Sugino H 1993 Molecular heterogeneity of FS, an activin binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. Journal of Biological Chemistry 268 15579-15587.
30. Sumitomo S, Inouye S, Liu X-J, Ling N & Shimasaki S 1995 The heparin binding site of FS is involved in its interaction with activin. Biochemical and Biophysical Research Communicatiotis 208 1-9.
31. Thomas TZ, Chapman SM, Wang H, Gurusinghe C, Mellor SL, Fletcher R, Pedersen J & Risbridger R 1997 Inhibins, activins and follistatins: expression of mRNAs and cellular localisation in tissues from men with benign prostatic hyperplasia. Prostate (In Press).
32. Wilding G, Zugmeier G, Knabbe C, Flanders K & Gelmann E 1989 Differential effects of transforming growth factor-β on human prostate cancer cells in vitro. Molecular and Cellular Endocrinology 62 79-87.
33. Ying S-Y, Zhang Z & Xing W 1995 Expression of activin and activin receptors in PC3 human prostatic cancer cells. International Journal of Oncology 6 601-606.